$12.59
4.22% today
Nasdaq, Nov 07, 04:48 pm CET
ISIN
US23725P1003
Symbol
DRIO

DarioHealth Corp. Stock price

$12.08
-3.73 23.59% 1M
-1.92 13.74% 6M
-3.64 23.17% YTD
-7.22 37.42% 1Y
-68.32 84.98% 3Y
-220.72 94.81% 5Y
-2,731.84 99.56% 10Y
-107,267.92 99.99% 20Y
Nasdaq, Closing price Thu, Nov 06 2025
-1.51 11.11%
ISIN
US23725P1003
Symbol
DRIO

Key metrics

Basic
Market capitalization
$81.8m
Enterprise Value
$90.1m
Net debt
$8.3m
Cash
$22.2m
Shares outstanding
2.3m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
3.0 | 3.3
EV/Sales
3.3 | 3.7
EV/FCF
negative
P/B
1.3
Financial Health
Equity Ratio
60.6%
Return on Equity
-56.9%
ROCE
-42.9%
ROIC
-55.2%
Debt/Equity
0.5
Financials (TTM | estimate)
Revenue
$27.2m | $24.4m
EBITDA
$-36.0m | $-22.3m
EBIT
$-42.3m | $-34.5m
Net Income
$-42.4m | $-61.6m
Free Cash Flow
$-26.9m
Growth (TTM | estimate)
Revenue
41.8% | -9.7%
EBITDA
37.2% | 55.0%
EBIT
32.8% | 39.4%
Net Income
8.8% | -50.3%
Free Cash Flow
34.2%
Margin (TTM | estimate)
Gross
55.0%
EBITDA
-132.5% | -91.2%
EBIT
-155.8%
Net
-156.3% | -252.3%
Free Cash Flow
-99.2%
More
EPS
$-17.1
FCF per Share
$-11.9
Short interest
3.2%
Employees
199
Rev per Employee
$140.0k
Show more

Is DarioHealth Corp. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,024 stocks worldwide.

DarioHealth Corp. Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a DarioHealth Corp. forecast:

8x Buy
80%
2x Hold
20%

Analyst Opinions

10 Analysts have issued a DarioHealth Corp. forecast:

Buy
80%
Hold
20%

Financial data from DarioHealth Corp.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
27 27
42% 42%
100%
- Direct Costs 12 12
8% 8%
45%
15 15
152% 152%
55%
- Selling and Administrative Expenses 39 39
15% 15%
142%
- Research and Development Expense 19 19
20% 20%
68%
-36 -36
37% 37%
-132%
- Depreciation and Amortization 6.32 6.32
10% 10%
23%
EBIT (Operating Income) EBIT -42 -42
33% 33%
-156%
Net Profit -42 -42
9% 9%
-156%

In millions USD.

Don't miss a Thing! We will send you all news about DarioHealth Corp. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

DarioHealth Corp. Stock News

Neutral
PRNewsWire
one day ago
Company to host conference call and webcast at 8:30 a.m. Eastern Time NEW YORK , Nov. 6, 2025 /PRNewswire/ --DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today that it will release its financial results for the 3rd quarter ended September 30 th, 2025 and will host a conference call and webcast at 8:30 a.m.
Neutral
PRNewsWire
9 days ago
NEW YORK , Oct. 29, 2025 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating DarioHealth Corp. (NASDAQ: DRIO) on behalf of the company's shareholders.  The investigation seeks to determine whether DarioHealth's directors breached their fiduciary duties in connection with recent corporate actions.
Neutral
PRNewsWire
25 days ago
New clients span multiple industries and underscore broad increasing demand for Dario's multi-condition digital health platform Innovative new pricing model is highly attractive to prospective clients – supports Dario's continued market momentum and leading position as value-based solution provider NEW YORK , Oct. 13, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Compan...
More DarioHealth Corp. News

Company Profile

DarioHealth Corp. is a digital therapeutics company, which engages in the research, development, and sale of pharmaceutical products. It offers a monitoring device, mobile application, and data services for diabetes management. Its solutions include MyDario, Daro Engage, and Dario Intelligence. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in Caesarea, Israel.

Head office United States
CEO Erez Raphael
Employees 199
Founded 2011
Website shop.mydario.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today